Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00263367|
Recruitment Status : Completed
First Posted : December 8, 2005
Last Update Posted : June 22, 2011
This study will look at the changes taking place in the blood levels of key markers of oxidative stress. Oxidative stress is the biological equivalent of rust on a car. It changes vital cell chemistry. It is known to occur at high pressure oxygen, but little is known about changes at pressures slightly greater than normal atmospheric pressure.
Hyperbaric therapy is used in a variety of medical conditions. It is being tested in this study only for safety. It is not being assessed for the ability of hyperbaric oxygen to improve the clinical condition of children with autism.
This study was felt to be important since autism appears to be associated with oxidative stress and hyperbarics was being used "off-label" for this condition without safety studies.
|Condition or disease||Intervention/treatment||Phase|
|Autism Oxidative Stress||Other: Hyperbaric Oxygen||Not Applicable|
Blood will be drawn immediately prior to a one hour session of hyperbarics (HBT. A catheter will be inserted in to a vein and converted to a heparin lock indwelling port for the next blood draw. The child (ages 5-12 years) will then undergo 1 hour of compression at 1.3 atmospheric pressure (4 psi above room air pressure). Supplemental oxygen will be provided to the child.
A second blood draw from the catheter site will be accomplished immediately after the child comes out of the HBT chamber.
These will be sent to the laboratories for evaluation of changes in reduced glutathione and lipid peroxides.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism: A Pilot Study|
|Study Start Date :||October 2005|
|Actual Primary Completion Date :||January 2006|
|Actual Study Completion Date :||February 2006|
hyperbaric oxygen at 1.3 ATA
Hyperbaric Oxygen at 1.3 ATA for one hour followed by measurement of glutathione in the blood
Other: Hyperbaric Oxygen
Hyperbaric Oxygen at 1.3 ATA for one hour
Other Name: HBOT
- glutathione [ Time Frame: 1 hour ]measurement of glutathione immediately after one hour of exposure to low dose HBOT
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00263367
|United States, Florida|
|Melbourne, Florida, United States, 32901|
|Principal Investigator:||James J Bradstreet, MD FAAFP||ICDRC|